Leah Christl

Leah Christl currently serves as Vice President of Global Regulatory Affairs and General Medicine Therapeutic Area Head at Amgen, where responsibilities include leading the global regulatory affairs team and developing regulatory strategies for biosimilars and general medicines. Prior to Amgen, Leah held multiple executive roles at the FDA from 2010 to 2019, focusing on the review and approval processes for therapeutic biological and biosimilar products. Early in the career, Leah gained experience at the FDA and as a Research Assistant Professor at the University of South Carolina. Leah earned a Ph.D. in Environmental Molecular Microbiology from the Medical University of South Carolina and a B.S. in Biology from Rochester Institute of Technology.